Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (11)
Tumor Biologic Factors and Breast Cancer Prognosis Among White, Hispanic, and Black Women in the United States
1994 • 426 citations
NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
1992 • 313 citations
DT-diaphorase and cancer chemotherapy
1992 • 284 citations
Reductase Enzyme Expression Across the National Cancer Institute Tumor Cell Line Panel: Correlation With Sensitivity to Mitomycin C and EO9
1996 • 232 citations
Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells.
1990 • 222 citations
DT-diaphorase in activation and detoxification of quinones
1993 • 188 citations
Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase.
1994 • 127 citations
The Role of NAD(P)H: Quinone Reductase (EC 1.6.99.2, DT-Diaphorase) in the Reductive Bioactivation of the Novel Indoloquinone Antitumor Agent E09
1991 • 122 citations
Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies.
1994 • 106 citations
Cancer in Hispanics: issues of concern.
1995 • 25 citations
Response to treatment of breast cancer
1991 • 5 citations